Literature DB >> 17401162

Construction of adenovirus type 5 early region 1 and 4 virus mutants.

Peter Groitl1, Thomas Dobner.   

Abstract

This chapter describes a novel strategy that simplifies the generation and production of adenovirus type 5 (Ad5) mutants carrying defined mutations in early transcription units 1 (E1) and 4 (E4). The strategy involves three recombinant plasmids containing E1 (pE1-1235), E4 (pE4-1155), or the wild-type genome that lacks a portion of E3 (pH5pg4100). To generate recombinant viruses, mutations are first introduced into pE1- and/or pE4-transfer plasmids by site-directed mutagenesis. The mutagenized constructs are then ligated into plasmid pH5pg4100 containing the Ad backbone by direct cloning. Infectious viral DNAs are released from the recombinant plasmids by PacI-digestion and transfected into the complementing cell lines 293 or W162, and viral progeny are isolated and amplified. The advantages of this strategy are multiple: all cloning steps are carried out in Escherichia coli, and any genetic region of the viral E1 and/or E4 transcription units can be specifically modified or deleted. Moreover, foreign genes can be introduced into the E1 and/or E4 regions, and expression of viral or therapeutic genes can be controlled by cell-type specific and/or inducible promoters.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401162     DOI: 10.1385/1-59745-166-5:29

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  36 in total

1.  DNA damage response signaling triggers nuclear localization of the chicken anemia virus protein Apoptin.

Authors:  Thomas J Kucharski; Isabelle Gamache; Ole Gjoerup; Jose G Teodoro
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

3.  Morphological, Biochemical, and Functional Study of Viral Replication Compartments Isolated from Adenovirus-Infected Cells.

Authors:  Paloma Hidalgo; Lourdes Anzures; Armando Hernández-Mendoza; Adán Guerrero; Christopher D Wood; Margarita Valdés; Thomas Dobner; Ramón A Gonzalez
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

Review 4.  Getting genetic access to natural adenovirus genomes to explore vector diversity.

Authors:  Wenli Zhang; Anja Ehrhardt
Journal:  Virus Genes       Date:  2017-07-15       Impact factor: 2.332

5.  Localization and importance of the adenovirus E4orf4 protein during lytic infection.

Authors:  Marie-Joëlle Miron; Paola Blanchette; Peter Groitl; Frederic Dallaire; Jose G Teodoro; Suiyang Li; Thomas Dobner; Philip E Branton
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

6.  Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex.

Authors:  Frédéric Dallaire; Paola Blanchette; Peter Groitl; Thomas Dobner; Philip E Branton
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  A proteomic approach to identify candidate substrates of human adenovirus E4orf6-E1B55K and other viral cullin-based E3 ubiquitin ligases.

Authors:  Frédéric Dallaire; Paola Blanchette; Philip E Branton
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

8.  The E3 ubiquitin ligase activity associated with the adenoviral E1B-55K-E4orf6 complex does not require CRM1-dependent export.

Authors:  Melanie Schmid; Kathrin Kindsmüller; Peter Wimmer; Peter Groitl; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

9.  The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription.

Authors:  Julia Berscheminski; Peter Groitl; Thomas Dobner; Peter Wimmer; Sabrina Schreiner
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

10.  MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma.

Authors:  Simone Braig; Daniel W Mueller; Tanja Rothhammer; Anja-Katrin Bosserhoff
Journal:  Cell Mol Life Sci       Date:  2010-05-18       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.